Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ASTEC LIFESCIENCES LIMITED Call Transcript 2021

Oct 20, 2021

61682_rns_2021-10-20_77aa7a75-292f-463e-bd82-076a75347b36.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [451 x 85] intentionally omitted <==

Date: 20[th] October, 2021

To, To, BSE Limited National Stock Exchange of India Limited P. J. Towers, Dalal Street, Fort, Exchange Plaza, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai – 400 051

Ref.: BSE Scrip Code No. “533138”

Ref.: “ASTEC”

Subject: Intimation of Schedule of Conference Call with Investors & Analysts to be held on Thursday, 28[th] October, 2021 at 2.00 p.m.

Dear Sir / Madam,

We have attached herewith a communication on the Schedule of Conference Call with the Investors and Analysts to be held on Thursday, 28[th] October, 2021 at 2.00 p.m. IST.

The aforesaid information is also being hosted on the website of the Company viz., www.astecls.com.

Please take the same on your records.

Thanking you,

Yours sincerely,

For Astec LifeSciences Limited

TEJASHREE Digitally signed by TEJASHREE ROHAN PRADHAN DN: c=IN, o=Personal, 2.5.4.20=d7353bf95b7d8de2bb8a40acecbf3d366b9b5474 ROHAN 85e521d767e1a5353c31c3a0, postalCode=400606, st=MAHARASHTRA, serialNumber=cc444393f2150dc819f3d8164db345c555b4 0cb184b6ae8611cda7b9d64587a7, cn=TEJASHREE ROHAN PRADHAN, l=THANE, PRADHAN pseudonym=22b31a79fb934b36b4be2e85835a9a14 Date: 2021.10.20 18:31:01 +05'30'

Tejashree Pradhan Company Secretary & Compliance Officer (FCS 7167)

==> picture [453 x 86] intentionally omitted <==

==> picture [596 x 76] intentionally omitted <==

==> picture [57 x 59] intentionally omitted <==

Astec LifeSciences

Q2FY22 Conference Call Invite

We are pleased to invite you to Q2FY22 Post Results Conference Call of Astec LifeSciences , a 63.32% subsidiary of Godrej Agrovet, on Thursday, October 28, 2021 at 2:00 PM IST . The company manufactures a wide range of agrochemicals – active ingredients and intermediate products.

The call will be initiated with a brief management discussion on Q2FY22 performance, followed by an interactive Question & Answer session.

Details of conference call

Date : Thursday,28thOctober 2021
Time : 2:00 PM IST
Call leader : Ankur Periwal,Axis Capital
Country Dial-in
Primary number +91 22 6280 1145
Secondary number +91 22 7115 8046
International dial-in
- HongKong 800 964 448
- Singapore 800 101 2045
- UK 0 808 101 1573
- USA 1 866 746 2133

Pre-register to avoid wait time:

https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=6246406&linkSecurityString=17f7bf8240

About Astec LifeSciences:

Astec LifeSciences is engaged in the manufacture and sale of agrochemical active ingredients (technical), bulk and formulations, and intermediate products. With over two decades of experience in development and production of select chemicals, Astec has forged enduring relationships with its customers all over the world. The company sells its products in India as well as exports them to approximately 24 countries.

In August 2015, erstwhile promoters of Astec LifeSciences sold 45.29% of its paid-up equity shares to Godrej Agrovet. As on September 30, 2021, Godrej Agrovet holds 63.32% stake in the company.

For further information, you may log on to http://www.astecls.com or please contact:

Ankur Periwal, CFA, FRM Saurav Bhala (ED – Spec Chem & Midcaps) CFO – Astec Lifesciences Ltd Axis Capital Godrej One, 3rd Floor, Vikhroli (E), Mumbai Direct: +91 22 4325 1149 Email: [email protected] Mobile: +91 98204 16359 Email: [email protected]